The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update

SA Jasim, RS Mahdi, DO Bokov… - Journal of Medical …, 2022 - Wiley Online Library
The precise interaction between the immune system and severe acute respiratory syndrome
coronavirus 2 (SARS‑CoV‑2) is critical in deciphering the pathogenesis of coronavirus …

Understanding COVID-19 pandemic: molecular mechanisms and potential therapeutic strategies. An evidence-based review

R Hanna, S Dalvi, T Sălăgean, ID Pop… - Journal of …, 2021 - Taylor & Francis
Abstract Initially, the SARS-CoV-2 virus was considered as a pneumonia virus; however, a
series of peer reviewed medical papers published in the last eight months suggest that this …

The novel insight of SARS-CoV-2 molecular biology and pathogenesis and therapeutic options

A Asghari, M Naseri, H Safari, E Saboory… - DNA and Cell …, 2020 - liebertpub.com
On December 31, 2019, a novel coronavirus, being the third highly infective CoV and named
as coronavirus disease 2019 (COVID-19) in the city of Wuhan, was announced by the World …

The prospects for the SARS‐CoV‐2 pandemic in Africa

V Quaresima, MM Naldini, DM Cirillo - EMBO Molecular Medicine, 2020 - embopress.org
On December 31, 2019, the Chinese government officially announced the identification of a
new type of coronavirus (SARS‐CoV‐2) as the etiological cause of a severe acute …

On the whereabouts of SARS-CoV-2 in the human body: A systematic review

W Trypsteen, J Van Cleemput, W Snippenberg… - PLoS …, 2020 - journals.plos.org
Since SARS-CoV-2 appeared in the human population, the scientific community has
scrambled to gather as much information as possible to find good strategies for the …

[HTML][HTML] Post-acute COVID-19 syndrome

A Nalbandian, K Sehgal, A Gupta, MV Madhavan… - Nature medicine, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen
responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in …

COVID-19: knowns, unknowns, and questions

S Weston, MB Frieman - Msphere, 2020 - Am Soc Microbiol
The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
from the Hubei province in China in late 2019 demonstrates the epidemic potential of …

Severe acute respiratory syndrome coronavirus 2: from gene structure to pathogenic mechanisms and potential therapy

J Wu, X Yuan, B Wang, R Gu, W Li, X Xiang… - Frontiers in …, 2020 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly emerging
respiratory virus with high morbidity, which was named coronavirus disease 2019 (COVID …

SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention

IS Mahmoud, YB Jarrar, W Alshaer, S Ismail - Biochimie, 2020 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new viral disease that
has gained global attention owing to its ability to provoke community and health-care …

Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications

IP Trougakos, K Stamatelopoulos, E Terpos… - Journal of Biomedical …, 2021 - Springer
Background Gaining further insights into SARS-CoV-2 routes of infection and the underlying
pathobiology of COVID-19 will support the design of rational treatments targeting the life …